Income Statement
STRUCTURE THERAPEUTICS INC.
GPCR
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY |
|---|---|---|---|
|
Revenue
|
- | - | - |
|
Cost of Revenue
|
- | - | - |
|
Gross Profit
|
- | - | - |
|
Operating Expenses
|
176.56 | 158.23 | 102.78 |
|
Research & Development
|
225.26 | 108.81 | 70.10 |
|
Selling, General & Administrative
|
61.55 | 49.41 | 32.67 |
|
Other Operating Expenses
|
- | - | - |
|
Operating Income
|
-176.56 | -158.23 | -102.78 |
|
Non-Operating Income
|
-35.87 | -36.01 | -13.39 |
|
Interest Income
|
- | - | - |
|
Interest Expense
|
- | - | - |
|
Other Non-Op Income / Expense
|
- | - | - |
|
Income Before Tax
|
-140.69 | -122.22 | -89.38 |
|
Income Tax Expense
|
0.52 | 0.31 | 0.24 |
|
Non-Controlling Interest
|
- | - | - |
|
Net Income
|
-141.20 | -122.53 | -89.62 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY |
|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - |
|
EBITDA
|
-176.56 | -158.23 | -102.78 |
|
Earnings Per Share (Basic)
|
-0.80 | -0.78 | -0.81 |
|
Diluted EPS
|
-0.80 | -0.78 | -0.81 |
|
Weighted Average Shares
|
177.60 | 157.92 | 110.20 |
|
Diluted Weighted Avg Shares
|
177.60 | 157.92 | 110.20 |
|
Comprehensive Income
|
-141.06 | -122.13 | -88.99 |